CMAX vs. AHI, DHAI, VENA, XELA, KITT, NXL, SPPL, EDTK, STBX, and TOMZ
Should you be buying CareMax stock or one of its competitors? The main competitors of CareMax include Advanced Health Intelligence (AHI), DIH Holding US (DHAI), Venus Acquisition (VENA), Exela Technologies (XELA), Nauticus Robotics (KITT), Nexalin Technology (NXL), Simpple (SPPL), Skillful Craftsman Education Technology (EDTK), Starbox Group (STBX), and TOMI Environmental Solutions (TOMZ). These companies are all part of the "business services" sector.
Advanced Health Intelligence (NASDAQ:AHI) and CareMax (NASDAQ:CMAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.
Advanced Health Intelligence has higher earnings, but lower revenue than CareMax.
CareMax received 8 more outperform votes than Advanced Health Intelligence when rated by MarketBeat users. However, 100.00% of users gave Advanced Health Intelligence an outperform vote while only 30.00% of users gave CareMax an outperform vote.
0.0% of Advanced Health Intelligence shares are owned by institutional investors. Comparatively, 65.9% of CareMax shares are owned by institutional investors. 16.0% of Advanced Health Intelligence shares are owned by insiders. Comparatively, 26.9% of CareMax shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
CareMax has a consensus target price of $45.00, indicating a potential upside of 1,280.37%. Given Advanced Health Intelligence's higher probable upside, analysts clearly believe CareMax is more favorable than Advanced Health Intelligence.
Advanced Health Intelligence has a beta of 3.27, meaning that its stock price is 227% more volatile than the S&P 500. Comparatively, CareMax has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.
In the previous week, CareMax had 3 more articles in the media than Advanced Health Intelligence. MarketBeat recorded 3 mentions for CareMax and 0 mentions for Advanced Health Intelligence. CareMax's average media sentiment score of 1.53 beat Advanced Health Intelligence's score of 0.04 indicating that Advanced Health Intelligence is being referred to more favorably in the media.
Advanced Health Intelligence has a net margin of 0.00% compared to Advanced Health Intelligence's net margin of -90.98%. CareMax's return on equity of 0.00% beat Advanced Health Intelligence's return on equity.
Summary
Advanced Health Intelligence beats CareMax on 8 of the 14 factors compared between the two stocks.
Get CareMax News Delivered to You Automatically
Sign up to receive the latest news and ratings for CMAX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CMAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
